395 related articles for article (PubMed ID: 9236431)
1. Association of an acute reduction in lipoprotein(a) with coronary artery restenosis after percutaneous transluminal coronary angioplasty.
Horie H; Takahashi M; Izumi M; Takaoka A; Fujita T; Sakamoto T; Kito O; Okamura H; Kinoshita M
Circulation; 1997 Jul; 96(1):166-73. PubMed ID: 9236431
[TBL] [Abstract][Full Text] [Related]
2. Can aggressive lipid lowering using low-density lipoprotein apheresis prevent restenosis after percutaneous transluminal coronary angioplasty in patients with normocholesterolemia?
Yamashita K; Tasaki H; Tsuda Y; Himeno E; Nakashima Y
Ther Apher; 1998 Aug; 2(3):210-7. PubMed ID: 10227772
[TBL] [Abstract][Full Text] [Related]
3. The relationship between serum lipoprotein(a) and restenosis after initial elective percutaneous transluminal coronary angioplasty.
Tenda K; Saikawa T; Maeda T; Sato Y; Niwa H; Inoue T; Yonemochi H; Maruyama T; Shimoyama N; Aragaki S
Jpn Circ J; 1993 Aug; 57(8):789-95. PubMed ID: 8355396
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein(a) level does not predict restenosis after percutaneous transluminal coronary angioplasty.
Alaigh P; Hoffman CJ; Korlipara G; Neuroth A; Dervan JP; Lawson WE; Hultin MB
Arterioscler Thromb Vasc Biol; 1998 Aug; 18(8):1281-6. PubMed ID: 9714135
[TBL] [Abstract][Full Text] [Related]
5. Serum lipids and lipoproteins in relation to restenosis after coronary angioplasty.
Johansson SR; Wiklund O; Karlsson T; Hjalmarson A; Emanuelsson H
Eur Heart J; 1991 Sep; 12(9):1020-8. PubMed ID: 1936002
[TBL] [Abstract][Full Text] [Related]
6. Prevention of restenosis after percutaneous transluminal coronary angioplasty by reducing lipoprotein (a) levels with low-density lipoprotein apheresis. Low-Density Lipoprotein Apheresis Angioplasty Restenosis Trial (L-ART) Group.
Daida H; Lee YJ; Yokoi H; Kanoh T; Ishiwata S; Kato K; Nishikawa H; Takatsu F; Kato H; Kutsumi Y
Am J Cardiol; 1994 Jun; 73(15):1037-40. PubMed ID: 8198026
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of LDL-apheresis in preventing restenosis after percutaneous transluminal coronary angioplasty (PTCA): LDL-apheresis angioplasty restenosis trial (L-ART).
Yamaguchi H; Lee YJ; Daida H; Yokoi H; Miyano H; Kanoh T; Ishiwata S; Kato K; Nishikawa H; Takatsu F
Chem Phys Lipids; 1994 Jan; 67-68():399-403. PubMed ID: 8187240
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of serum lipoprotein (a) as a predictor of restenosis after percutaneous transluminal coronary angioplasty.
Hearn JA; Donohue BC; Ba'albaki H; Douglas JS; King SB; Lembo NJ; Roubin GS; Sgoutas DS
Am J Cardiol; 1992 Mar; 69(8):736-9. PubMed ID: 1532112
[TBL] [Abstract][Full Text] [Related]
9. Serum lipids and restenosis after successful percutaneous transluminal coronary angioplasty. Ichilov Magnesium Study Group.
Roth A; Eshchar Y; Keren G; Sheps D; Kerbal S; Laniado S; Miller HI; Rubinstein A
Am J Cardiol; 1994 Jun; 73(16):1154-8. PubMed ID: 8203331
[TBL] [Abstract][Full Text] [Related]
10. [Normalization of lipid metabolism disturbances and clinical course after percutaneous coronary angioplasty: 6 month observation].
Ochała A; Gabrylewicz B; Bartnik M; Garbocz P; Wycisk A; Lewicki A; Kaźmierski M; Tendera M
Pol Arch Med Wewn; 2000 Dec; 104(6):833-41. PubMed ID: 11424662
[TBL] [Abstract][Full Text] [Related]
11. Restenosis after transluminal coronary angioplasty: a risk factor analysis.
Gürlek A; Dağalp Z; Oral D; Omürlü K; Erol C; Akyol T; Tutar E
J Cardiovasc Risk; 1995 Feb; 2(1):51-5. PubMed ID: 7606641
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein(a) in restenosis after percutaneous transluminal coronary angioplasty and coronary artery disease.
Cooke T; Sheahan R; Foley D; Reilly M; D'Arcy G; Jauch W; Gibney M; Gearty G; Crean P; Walsh M
Circulation; 1994 Apr; 89(4):1593-8. PubMed ID: 8149526
[TBL] [Abstract][Full Text] [Related]
13. Absence of relationship between plasma Lp(a), Lp-AI, anti-oxidized LDL autoantibodies, LDL immune complexes concentrations and restenosis after percutaneous transluminal coronary angioplasty.
Boullier A; Walters-Laporte E; Hamon M; Tailleux A; Amant C; Amouyel P; Fruchart J; Bertrand M; Duriez P
Clin Chim Acta; 2000 Sep; 299(1-2):129-40. PubMed ID: 10900299
[TBL] [Abstract][Full Text] [Related]
14. [The importance of serum lipid level for restenosis following initial successful percutaneous transluminal coronary angioplasty in patients with unstable angina].
Kishi K; Hiasa Y; Tanaka H; Tanimoto M; Kinoshita M; Shinohara A; Wada T; Aihara T
J Cardiol; 1996 Aug; 28(2):79-84. PubMed ID: 8814525
[TBL] [Abstract][Full Text] [Related]
15. Elevated serum lipoprotein(a) is a risk factor for clinical recurrence after coronary balloon angioplasty.
Desmarais RL; Sarembock IJ; Ayers CR; Vernon SM; Powers ER; Gimple LW
Circulation; 1995 Mar; 91(5):1403-9. PubMed ID: 7867180
[TBL] [Abstract][Full Text] [Related]
16. [Preventive effect of pravastatin on restenosis following coronary angioplasty: prospective randomized trial].
Iwasaki K; Kusachi S; Hina K; Yamasaki S; Nishiyama O; Takaishi A; Kita T; Taniguchi G
J Cardiol; 1995 Jan; 25(1):15-21. PubMed ID: 7877098
[TBL] [Abstract][Full Text] [Related]
17. High serum concentration of lipoprotein(a) is a risk factor for restenosis after percutaneous transluminal coronary angioplasty in Japanese patients with single-vessel disease.
Miyata M; Biro S; Arima S; Hamasaki S; Kaieda H; Nakao S; Kawataki M; Nomoto K; Tanaka H
Am Heart J; 1996 Aug; 132(2 Pt 1):269-73. PubMed ID: 8701886
[TBL] [Abstract][Full Text] [Related]
18. Short-term and long-term effects of low-density lipoprotein (LDL) apheresis on restenosis after percutaneous transluminal coronary angioplasty (PTCA): is lowering Lp(a) by LDL apheresis effective on restenosis after PTCA?
Kanemitsu S; Takekoshi N; Matsui S; Tsugawa H; Ohkubo S; Kitayama M; Matsuda T; Senma J; Masuyama K; Yamagata T; Murakami E
Ther Apher; 1998 Feb; 2(1):65-70. PubMed ID: 10227791
[TBL] [Abstract][Full Text] [Related]
19. Influence of serum cholesterol and cholesterol subfractions on restenosis after successful coronary angioplasty. A quantitative angiographic analysis of 3336 lesions.
Violaris AG; Melkert R; Serruys PW
Circulation; 1994 Nov; 90(5):2267-79. PubMed ID: 7955183
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein (a) and anticardiolipin antibodies are risk factors for clinically relevant restenosis after elective balloon percutaneous transluminal coronary angioplasty.
Chiarugi L; Prisco D; Antonucci E; Capanni M; Fedi S; Liotta AA; Margheri M; Simonetti I; Gensini GF; Abbate R
Atherosclerosis; 2001 Jan; 154(1):129-35. PubMed ID: 11137091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
